Patients fund the research they want

Wednesday, 2 December 2015

A group of scientists have launched a crowd-sourcing project to fund research into using anti-malarial drugs to address colorectal cancer.

Scientists at St George’s, University of London, and St George’s Hospital have already exceeded their target of £50,000 from more than 300 backers. 

The official campaign page says:

Colorectal cancer is the 3rd most common cancer world-wide. There is an urgent need to improve survival rates. Our research is looking at whether we can use artesunate, an existing and safe anti-malarial drug, in a new way to improve survival from colorectal cancer. Repurposing established drugs to treat cancer in this way removes some of the delays and barriers faced when trying to develop effective new treatments.

A new approach to research?

Scientists, patients and the public have worked together to fund research into an area they care about. Crowd-sourcing could open the door to more patient-led funding in the future. Patients could identify an interest, group together to raise funds and then commission research themselves.

Find out more

Read more about the campaign and see the official giving page too.